đź“• Make Better Decisions: Finding and Evaluating Generic and Branded Drug Market Entry Opportunities
New book based on 20 years providing business guidance to drug companies [Free Sample]  [Buy printed book from Amazon] [More Details] Make […]
Uncategorized
First Generic Launch has Significant First-Mover Advantage Over Later Generic Drug Entrants
Generic drugs perform better financially if they get to market first. The advantage is amplified if they get there more than one month ahead of competitors.
The post First Generic Launch has Significant First-Mover Advantage Over Later Generic Drug Ent…
Uncategorized
6 Ways to Maximize Product Value as Loss of Exclusivity Approaches
Loss of exclusivity doesn’t mean the end of the income stream for branded drugs. Here’s how drug companies can mitigate the effects of drug patent expiration.
The post 6 Ways to Maximize Product Value as Loss of Exclusivity Approaches appeared first on…
6 Ways to Maximize Product Value as Loss of Exclusivity Approaches Read Post »
Featured, Update
DrugPatentWatch Alternatives
Considering switching to DrugPatentWatch? See why others have come to us. Switch to DrugPatentWatch
The post DrugPatentWatch Alternatives appeared first on DrugPatentWatch – Make Better Decisions.
Insights
Review of Drugs Approved via the 505(b)(2) Pathway: Uncovering Drug Development Trends and Regulatory Requirements
This paper was originally published by Ingrid Freije, StĂ©phane Lamouche, and Mario Tanguay in Therapeutic Innovation & Regulatory Science under a Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/…
Uncategorized
Generic Drug Market Entry in Europe: Why a Tailored Approach Is Best
Generic drug makers must tailor European market entry strategies to each country. Moreover, they must address the sequence in which they want to enter markets.
The post Generic Drug Market Entry in Europe: Why a Tailored Approach Is Best appeared first…
Generic Drug Market Entry in Europe: Why a Tailored Approach Is Best Read Post »
Books, Featured, Insights
Make Better Decisions: Finding and Evaluating Generic and Branded Drug Market Entry Opportunities
BIO Attendees – Get a free preview of our book when it launches on July 1st Name Email HP Make Better Decisions helps generic and branded companies alike find and evaluate…
The post Make Better Decisions: Finding and Evaluating Generic and Branded Drug…
Insights
Formulary Management and LCM Patent Strategies: A Complex Interaction
Drug patent expiration doesn’t always mean generics enter the market right away. Many factors affect generic drug launches and drug formulary changes.
The post Formulary Management and LCM Patent Strategies: A Complex Interaction appeared first on Drug…
Formulary Management and LCM Patent Strategies: A Complex Interaction Read Post »
Insights
5 Steps to Take When Your Drug Patent is About to Expire
There’s no reason to assume that every branded drug will fall victim to the “patent cliff.” Actions taken before drug patent expiration can extend drug life cycles.
The post 5 Steps to Take When Your Drug Patent is About to Expire appeared first on Dru…
5 Steps to Take When Your Drug Patent is About to Expire Read Post »
Insights
Will AI Help Challenge Drug Patents, or Strengthen Them?
Artificial intelligence is allowing chemists to find new way to synthesize drug molecules, and forcing drug developers to shore up their patent strategies.
The post Will AI Help Challenge Drug Patents, or Strengthen Them? appeared first on DrugPatentWa…
Will AI Help Challenge Drug Patents, or Strengthen Them? Read Post »
